n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Disease Models, Animal in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 32 (58.18) | 29.6817 |
2010's | 20 (36.36) | 24.3611 |
2020's | 3 (5.45) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Herms, F; Hofmann, L; Hurst, J; Joachim, SC; Kuehn, S; Mueller-Buehl, AM; Schnichels, S | 1 |
Pallone, TL; Payne, K; Zhang, Z | 1 |
Barrett-Jolley, R; Djouhri, L; Staunton, CA; Thippeswamy, T | 1 |
Han, S; Wang, B | 1 |
Anantharam, V; Gage, M; Gasser, G; Gregory-Flores, A; Hinojo-Perez, A; Olson, A; Putra, M; Puttachary, S; Sharma, S; Thippeswamy, T; Wang, C | 1 |
Bloomfield, PS; Chapple, KJ; Davies, AL; Desai, RA; Diem, R; Fairless, R; Kasti, M; Linington, C; McIntosh, PR; Murphy, MP; Smith, KJ | 1 |
Chen, TH; Liao, FT; Wang, JJ; Yang, YC | 2 |
Du, Y; Hao, L; Liu, Y; Lu, Q; Qin, W; Sheng, L; Wang, J; Wang, X; Wang, Y; Zhang, M; Zhao, T | 1 |
Breitinger, HG; El-Sayed, NS; Gad, MZ; Maher, A | 1 |
Luo, D; Putra, M; Puttachary, S; Sharma, S; Thippeswamy, A; Thippeswamy, T; Verma, S; Yang, Y | 1 |
Bennett, LD; Birch, DG; Carr, BC; Emigh, CE; Nguyen, C; Pansick, AD | 1 |
Hiroaki-Sato, VA; Joca, SR; Sales, AJ | 1 |
Bland, KI; Chaudry, IH; Choudhry, MA; Hsu, JT; Kan, WH; Raju, R; Schwacha, MG | 1 |
Dieterich, HJ; Goedhart, PT; Ince, C; Johannes, T; Klingel, K; Mik, EG; Nohé, B; Unertl, KE; Zanke, C | 1 |
Akgul, EO; Cayci, T; Cetiner, S; Ersoz, N; Guven, A; Korkmaz, A; Oztas, E; Turk, E; Uysal, B | 1 |
Benetti, LR; Conran, N; Fernandes, LG; Ferreira, HH; Guimarães, Lde A; Pelaquini, EH; Tamashiro, WM | 1 |
Gao, HM; Hong, JS; Kam, W; Wilson, B; Zhang, F; Zhou, H | 1 |
Abraldes, JG; Bosch, J; García-Pagán, JC; La Mura, V; Pasarín, M; Rodríguez-Vilarrupla, A | 1 |
Cobb, BA; Lewis, CJ | 1 |
Gobbato, NB; Leick, EA; Maciel, RG; Martins, MA; Prado, CM; Souza, FC; Tibério, IF | 1 |
Cavalcante Melo, FH; de Carvalho Lima, CN; de França Fonteles, MM; Freire Vasconcelos, L; Leite Dias, M; Moura Rocha, NF; Rodrigues Carvalho, AM; Soares Lopes, K; Vasconcelos Rios, ER | 1 |
Botten, J; Davis, IC; Hjelle, B; Matalon, S; Nolte, KB; Zajac, AJ | 1 |
Bauer, TW; Buerk, DG; Fraker, DL; Kelley, ST; Menon, C | 1 |
Asfar, P; Brückner, UB; Fröba, G; Georgieff, M; Ince, C; Nalos, M; Pittner, A; Radermacher, P; Yang, Y | 1 |
Battram, CH; Belvisi, MG; Birrell, MA; Foster, ML; Haddad, el-B; McCluskie, K; Webber, SE; Yacoub, MH | 1 |
Georgieff, M; Jauch, KW; Matejovic, M; Ploner, F; Radermacher, P; Stehr, A; Theisen, M; Tugtekin, I; Zülke, C | 1 |
Bachetti, T; Ferrari, R; Pasini, E; Suzuki, H | 1 |
Anning, PB; Evans, TW; Mitchell, JA; Price, S | 1 |
Abdelrahman, M; Cuzzocrea, S; McDonald, M; Thiemermann, C | 1 |
Bunge, MB; Chatzipanteli, K; Dietrich, WD; Marcillo, AE; Pearse, DD | 1 |
Slomiany, A; Slomiany, BL | 1 |
Alborch, E; Burguete, MC; Castillo, J; Hurtado, O; Knowles, RG; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA; Pérez-Asensio, FJ; Salom, JB; Torregrosa, G | 1 |
Besson, VC; Bohme, GA; Jafarian-Tehrani, M; Louin, G; Marchand-Verrecchia, C; Plotkine, M; Royo, NC | 1 |
Bonnefont-Rousselot, D; Jafarian-Tehrani, M; Lerouet, D; Louin, G; Margaill, I; Palmier, B; Plotkine, M | 1 |
Mark, LA; Robinson, AV; Schulak, JA | 1 |
Mayr, FB; Spiel, AO | 1 |
Boer, R; Ghofrani, HA; Grimminger, F; Lehner, M; Maring, D; Mayer, K; Pullamsetti, SS; Rosengarten, B; Schermuly, RT; Schudt, C; Seeger, W; Weissmann, N | 1 |
Fitzsimmons, B; Hua, XY; Svensson, CI; Tang, Q; Webb, M; Yaksh, TL | 1 |
Bobadilla, NA; Chirino, YI; Cruz, C; Martínez-Martínez, CM; Pedraza-Chaverri, J; Sánchez-González, DJ; Trujillo, J | 1 |
Akita, Y; Imamura, H; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K | 1 |
Gilroy, DW; Paul-Clark, MJ; Tomlinson, A; Willis, D; Willoughby, DA | 1 |
Beck, KF; Eberhardt, W; Pfeilschifter, J; Raslik, I; Schaefer, L; Schaefer, RM; Walpen, S | 1 |
Alvarez, E; Colón, AL; Leza, JC; Lizasoain, I; Lorenzo, P; Menchén, LA; Menchén, P; Moro, MA | 1 |
Folkerts, G; Koster, AS; Muijsers, RB; Nijkamp, FP; Postma, DS; van Ark, I; van Oosterhout, AJ | 1 |
Cerwinka, WH; Granger, DN; Grisham, MB; Krieglstein, CF; Laroux, FS; Ross, CR; Russell, JM; Salter, JW; Schuermann, G | 1 |
Courtois, Y; Goureau, O; Sennlaub, F | 1 |
Chiang, CP; Huang, CF; Lee, MY; Liu, HY; Sun, GH; Sun, KH; Tang, SJ; Tsou, YC | 1 |
Fu, J; Liu, X; Liu, Z; Ran, J; Shi, Q; Wang, N; Zheng, J; Zheng, X | 1 |
Li, Q; Liu, K; Zhang, L; Zheng, X | 1 |
Aker, S; Boengler, K; Canton, M; Deindl, E; Di Lisa, F; Heusch, G; Heusch, P; Klein, K; Konietzka, I; Menazza, S; Rassaf, T; Schulz, R; Sewell, A; van de Sand, A | 1 |
Andreadou, I; Bastounis, E; Gorgoulis, VG; Kotsinas, A; Kremastinos, D; Papalambros, E; Sigala, F; Sigalas, P | 1 |
Kennison, SD; Mercer, DW; Robinson, EK; Suliburk, JW | 1 |
Amato, A; Feo, S; Mulè, F; Serio, R; Zizzo, MG | 1 |
1 trial(s) available for n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal
Article | Year |
---|---|
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Micronutrients; Organophosphorus Compounds; Oxygen; Rats; Recovery of Function; Severity of Illness Index; Single-Blind Method; Spinal Cord Diseases; Ubiquinone | 2013 |
54 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model.
Topics: Amacrine Cells; Amidines; Animals; Apoptosis; Benzylamines; Cell Hypoxia; Disease Models, Animal; Humans; Microglia; Neuroprotection; Neuroprotective Agents; Nitric Oxide Synthase Type II; Organ Culture Techniques; Retina; Retinal Diseases; Retinal Ganglion Cells; Swine | 2020 |
Adaptive responses of rat descending vasa recta to ischemia.
Topics: Adaptation, Physiological; Amidines; Angiotensin II; Animals; Arterioles; Benzylamines; Constriction; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Humans; Ischemia; Kidney; Membrane Potentials; Nitric Oxide; Nitric Oxide Synthase Type II; Pericytes; Rats, Sprague-Dawley; Renal Artery; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents | 2018 |
Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model.
Topics: Amidines; Animals; Benzylamines; Cytokines; Disease Models, Animal; Male; Neuralgia; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Wistar | 2018 |
Inhibition of Inducible Nitric Oxide Synthase Attenuates Deficits in Synaptic Plasticity and Brain Functions Following Traumatic Brain Injury.
Topics: Amidines; Animals; Benzylamines; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Functional Laterality; In Vitro Techniques; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Patch-Clamp Techniques; Postural Balance; Recognition, Psychology; RNA, Messenger; Time Factors; Up-Regulation | 2018 |
Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.
Topics: Amidines; Animals; Benzylamines; Brain; Disease Models, Animal; Enzyme Inhibitors; Isoflurophate; Male; Nerve Agents; Nerve Degeneration; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley | 2020 |
Inhibition of inducible nitric oxide synthesis ameliorates liver ischemia and reperfusion injury induced transient increase in arterial stiffness.
Topics: Amidines; Animals; Benzylamines; Biomarkers; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Inflammation Mediators; Liver; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Pulse Wave Analysis; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors; Vascular Stiffness | 2014 |
Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury - induced acute renal injury.
Topics: Acute Kidney Injury; Amidines; Animals; Benzylamines; Biomarkers; Blood Pressure; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Injections, Intraperitoneal; Kidney; Male; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; Time Factors | 2014 |
Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
Topics: Amidines; Animals; Apoptosis; Benzylamines; Cardiotonic Agents; Caspase 3; Disease Models, Animal; Enzyme Inhibitors; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type II; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Ventricular Function | 2015 |
Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: modulation by NOS inhibitors.
Topics: Alzheimer Disease; Amidines; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Benzylamines; Brain; Diflunisal; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Gene Expression Regulation; Inflammation; Lipopolysaccharides; Male; Maze Learning; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Receptors, N-Methyl-D-Aspartate | 2014 |
1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male; Neurons; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; Status Epilepticus | 2016 |
TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.
Topics: Amidines; Animals; Aqueous Humor; Benzylamines; Diabetic Retinopathy; Disease Models, Animal; Electroretinography; Enzyme Inhibitors; Guanidines; Intraocular Pressure; Intravitreal Injections; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Rabbits; Retina; Vitreous Body | 2017 |
Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test.
Topics: Amidines; Animals; Arginine; Benzylamines; Disease Models, Animal; Hippocampus; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxadiazoles; Rats; Rats, Wistar; Soluble Guanylyl Cyclase; Stress, Psychological; Swimming; Time Factors | 2017 |
Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.
Topics: Amidines; Animals; Benzylamines; Blood Pressure; Chemokines; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fluid Therapy; Glutathione Transferase; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Adhesion Molecule-1; Isoenzymes; Liver; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peroxidase; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Tyrosine; Wounds and Injuries | 2008 |
Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats.
Topics: Acute Kidney Injury; Amidines; Anesthesia, General; Animals; Benzylamines; Biomarkers; Creatinine; Disease Models, Animal; Endotoxemia; Enzyme Inhibitors; Fluid Therapy; Glomerular Filtration Rate; Hemodynamics; Kidney; Lipopolysaccharides; Male; Microcirculation; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitroglycerin; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Wistar; Renal Circulation; RNA, Messenger; Time Factors | 2009 |
Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS.
Topics: Amidines; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Kidney; Kidney Diseases; Male; Melatonin; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2009 |
Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice.
Topics: Amidines; Animals; Benzylamines; Bone Marrow; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Eosinophils; Female; Hypersensitivity; Integrin alpha4beta1; Leukocyte Count; Lung; Macrophage-1 Antigen; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Ovalbumin; Th2 Cells | 2011 |
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Topics: alpha-Synuclein; Amidines; Animals; Animals, Genetically Modified; Benzylamines; Disease Models, Animal; Injections, Intraperitoneal; Lewy Bodies; Lipopolysaccharides; Mice; NADPH Oxidases; Nerve Degeneration; Neurodegenerative Diseases; Nitric Oxide Synthase Type II; Onium Compounds; Oxidative Stress; Parkinson Disease; Substantia Nigra | 2011 |
Insulin resistance and liver microcirculation in a rat model of early NAFLD.
Topics: Acetylcholine; Amidines; Animals; Benzylamines; Diet, High-Fat; Disease Models, Animal; Endothelium; Enzyme Inhibitors; Fatty Liver; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Liver Circulation; Male; Metformin; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Phosphorylation; Rats; Rats, Wistar; Up-Regulation; Vasodilation; Vasodilator Agents | 2011 |
Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.
Topics: Adaptive Immunity; Adoptive Transfer; Amidines; Animals; Antigen Presentation; Benzylamines; Cells, Cultured; Disease Models, Animal; Glycoproteins; Granuloma; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Th1 Cells | 2011 |
Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation.
Topics: Acetates; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Chronic Disease; Cyclopropanes; Cytokines; Dexamethasone; Disease Models, Animal; Enzyme Inhibitors; Eosinophils; Guinea Pigs; Lung; Male; Ovalbumin; Pneumonia; Quinolines; Statistics, Nonparametric; Sulfides | 2013 |
Involvement of the nitric oxide/cyclic guanylate monophosphate pathway in the pilocarpine-induced seizure model in mice.
Topics: Amidines; Animals; Arginine; Benzylamines; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Guanylate Cyclase; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Pilocarpine; Receptors, Cytoplasmic and Nuclear; Seizures; Soluble Guanylyl Cyclase | 2013 |
Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.
Topics: Adolescent; Adult; Amidines; Animals; Benzylamines; Blood Proteins; Case-Control Studies; Disease Models, Animal; Disease Vectors; Enzyme Inhibitors; Female; Hantavirus Pulmonary Syndrome; Humans; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Mice; Mice, Inbred NZB; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Orthohantavirus; Peromyscus; Reactive Nitrogen Species; Reactive Oxygen Species; Sin Nombre virus; Tyrosine | 2002 |
Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.
Topics: Acidosis; Amidines; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Female; Hindlimb; Humans; Melanoma; Melphalan; Nitric Oxide; Rats; Rats, Nude; Regional Blood Flow; Skin Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia.
Topics: Acidosis; Amidines; Animals; Benzylamines; Blood Gas Analysis; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxemia; Hemodynamics; Ileum; Intestinal Mucosa; Laser-Doppler Flowmetry; Microcirculation; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prospective Studies; Random Allocation; Spectrophotometry; Swine | 2003 |
Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation.
Topics: Amidines; Animals; Benzylamines; Bronchi; Cytokines; Dexamethasone; Dextrans; Disease Models, Animal; Enzyme Inhibitors; Eosinophilia; Eosinophils; Inflammation; Lung; Male; Neutrophils; Nitric Oxide Synthase; Protein Isoforms; Rats; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger | 2003 |
Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endotoxemia; Energy Metabolism; Female; Hemodynamics; Intestinal Mucosa; Lipopolysaccharides; Liver Circulation; Male; Niacinamide; Nitric Oxide Synthase; Poly(ADP-ribose) Polymerase Inhibitors; Prospective Studies; Pulmonary Circulation; Random Allocation; Splanchnic Circulation; Swine; Time Factors | 2003 |
Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
Topics: Amidines; Animals; Benzylamines; Blood Pressure; Breath Tests; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxemia; Escherichia coli Infections; Lipopolysaccharides; Luminescent Measurements; Lung; Male; Myocardium; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Prospective Studies; Rabbits; Random Allocation; Rats; Species Specificity | 2003 |
Type II nitric oxide synthase activity is cardio-protective in experimental sepsis.
Topics: Amidines; Animals; Benzylamines; Cardiotonic Agents; Disease Models, Animal; Enzyme Inhibitors; Heart; Heart Function Tests; Lipopolysaccharides; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Sepsis | 2003 |
Tyrphostin reduces the organ injury in haemorrhagic shock: role of inducible nitric oxide synthase.
Topics: Amidines; Animals; Benzylamines; Creatine Kinase; Disease Models, Animal; Immunohistochemistry; Kidney; Liver; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Pancreas; Protein-Tyrosine Kinases; Rats; Shock, Hemorrhagic; Tyrphostins | 2003 |
Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury.
Topics: Amidines; Animals; Annexins; Astrocytes; Benzylamines; Blood-Brain Barrier; Cell Count; Cell Death; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Female; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Guanidines; Immunoglobulin G; Immunohistochemistry; Laminectomy; Motor Neurons; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides, Antisense; Organic Chemicals; Peroxidase; Phosphopyruvate Hydratase; Propidium; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 2003 |
Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
Topics: Amidines; Androstadienes; Animals; Apoptosis; Benzylamines; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Ginkgolides; Glucosamine; Lactones; Lipopolysaccharides; Mucins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Activating Factor; Porphyromonas gingivalis; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Sublingual Gland; Tritium; Tumor Necrosis Factor-alpha; Up-Regulation; Wortmannin | 2004 |
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Cerebral Infarction; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Glutamic Acid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Stroke; Treatment Outcome | 2005 |
1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats.
Topics: Amidines; Animals; Benzylamines; Brain Injuries; Calcium; Disease Models, Animal; Enzyme Inhibitors; Male; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Lack of iNOS induction in a severe model of transient focal cerebral ischemia in rats.
Topics: Amidines; Analysis of Variance; Animals; Anticoagulants; Benzylamines; Blotting, Western; Brain; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edetic Acid; Enzyme Inhibitors; Inhibitory Concentration 50; Ischemic Attack, Transient; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors | 2005 |
Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
Topics: Amidines; Animals; Benzylamines; Creatinine; Disease Models, Animal; Endothelins; Enzyme Inhibitors; Kidney Tubules; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tyrosine | 2005 |
NO-synthase inhibition in sepsis.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Humans; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Sepsis; Shock, Septic | 2006 |
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Epinephrine; Hemoglobins; Male; Microcirculation; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Wistar; Shock, Septic | 2006 |
Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation.
Topics: Amidines; Animals; Benzylamines; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Hyperalgesia; Inflammation; Inflammation Mediators; Male; MAP Kinase Signaling System; Neurons, Afferent; Nitric Oxide; Nitric Oxide Synthase Type II; Nociceptors; p38 Mitogen-Activated Protein Kinases; Pain Measurement; Rats; Rats, Sprague-Dawley; Spinal Cord | 2007 |
Selective iNOS inhibition reduces renal damage induced by cisplatin.
Topics: Aldehydes; Amidines; Animals; Antineoplastic Agents; Benzylamines; Cisplatin; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Tyrosine | 2008 |
Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
Topics: Aldehydes; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hypertension; Losartan; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Tiopronin; Up-Regulation; Ventricular Function, Left | 2008 |
Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration.
Topics: Acute Disease; Amidines; Animals; Antioxidants; Benzylamines; Carrageenan; Disease Models, Animal; Drug Administration Schedule; Edema; Enzyme Inhibitors; Free Radical Scavengers; Inflammation; Inflammation Mediators; Injections; Injections, Intraperitoneal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Pleura; Pleurisy; Rats; Rats, Wistar; Superoxides; Thiourea | 2001 |
Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis.
Topics: Amidines; Animals; Benzylamines; Chemokine CXCL2; Chemokines; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Genes, Reporter; Glomerular Mesangium; Glomerulonephritis; Interleukin-1; Kidney Glomerulus; Lysine; Mutagenesis, Site-Directed; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins | 2001 |
N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats.
Topics: Amidines; Animals; Benzylamines; Blotting, Western; Colitis; Colon; Disease Models, Animal; Drug Administration Schedule; Enzyme Activation; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2001 |
Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice.
Topics: Acetophenones; Amidines; Animals; Antioxidants; Benzylamines; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Enzyme Inhibitors; Eosinophils; Hypersensitivity; Immunoglobulin E; Immunohistochemistry; Interferon-gamma; Interleukin-4; Interleukin-5; Lung; Male; Mice; Mice, Inbred BALB C; Neutrophils; Nitric Oxide Synthase; Ovalbumin; Specific Pathogen-Free Organisms; Tyrosine | 2001 |
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide.
Topics: Amidines; Animals; Benzylamines; Colitis, Ulcerative; Colon; Dextran Sulfate; Digestive System; Digestive System Physiological Phenomena; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NADPH Oxidases; Neutrophil Infiltration; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphoproteins; Reactive Oxygen Species; Specific Pathogen-Free Organisms; Superoxide Dismutase; Superoxides; Time Factors; Tumor Necrosis Factor-alpha | 2001 |
Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.
Topics: Aging; Amidines; Animals; Animals, Newborn; Apoptosis; Benzylamines; Cell Count; Crosses, Genetic; Diabetic Retinopathy; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxygen; Proteins; Retina; Retinal Diseases; Retinal Vein Occlusion; Tyrosine | 2002 |
Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90.
Topics: Animals; Asthma; Cells, Cultured; Cytokines; Disease Models, Animal; Female; HSP90 Heat-Shock Proteins; I-kappa B Kinase; Imines; Inflammation; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase; Ovalbumin; S-Nitroso-N-Acetylpenicillamine; Signal Transduction | 2015 |
1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia.
Topics: Animals; Annexin A5; Apoptosis; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Hypoxia; Imines; Lipid Peroxidation; Malondialdehyde; Maze Learning; Microglia; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase Type II; Oxygen; Rats; Rats, Sprague-Dawley; Tyrosine | 2017 |
The dynamic detection of NO during stroke and reperfusion in vivo.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Imines; Indazoles; Infusions, Intravenous; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2009 |
Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
Topics: Animals; Arginase; Arginine; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal; Enzyme Inhibitors; Heart Failure; Heart Rate; Imines; Male; Microscopy, Confocal; Myocardial Contraction; Myocardium; Nitrates; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Protein Processing, Post-Translational; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke Volume; Superoxides; Up-Regulation; Ventricular Function, Left | 2010 |
Relationship between iNOS expression and aortic cell proliferation and apoptosis in an elastase-induced model of aorta aneurysm and the effect of 1400 W administration.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Cell Division; Disease Models, Animal; Enzyme Inhibitors; Imines; Immunohistochemistry; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pancreatic Elastase; Rats; Rats, Wistar | 2005 |
Rat gastric injury after lipopolysaccharide: role of inducible nitric oxide synthase.
Topics: Animals; Disease Models, Animal; Female; Gastric Juice; Gastric Mucosa; Imines; Lipopolysaccharides; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats | 2005 |
Evidence for a role of inducible nitric oxide synthase in gastric relaxation of mdx mice.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Imines; Male; Mice; Mice, Inbred mdx; Muscle Relaxation; Muscle, Smooth; Muscular Dystrophy, Duchenne; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Organ Culture Techniques; Oxadiazoles; Quinoxalines; Receptors, Vasoactive Intestinal Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach; Vasoactive Intestinal Peptide | 2006 |